IONS IONIS PHARMACEUTICALS INC Product Launches 8-K Filing 2023 - FDA Approval Ionis Pharmaceuticals announced that the FDA has approved their drug WAINUA for the treatment of polyneuropathy in adults with hereditary transthyretin-mediated amyloidosis.Get access to all SEC 8-K filings of the IONIS PHARMACEUTICALS INC